In a really, really big way: "growing demand for expensive specialty drugs helped increase revenue from its pharmacy benefits management, or PBM, business nearly 22 percent in the quarter to $23.9 billion."
But there is more to the surge in specialty pharmacy driven profits..It's how CVS and other PBMs are raking in big discounts from makers of specialty drugs and then making it harder for patients to get them. From Rollcall:
Study: Higher Share of Plans Charging Patients Higher Fees for Certain Drugs"More health insurance plans on the exchanges are placing drugs to treat complex diseases at the highest cost-sharing tier in 2015 when compared to the previous year, according to a new analysis from the Avalere Health consulting firm."
I wrote about this pyramid scheme in my NY Post article. WIth exception of Adam Fein, no one else seems to cover this issue or care.
That's because it doesn't fit the narrative of BIG Pharma generating huge profits at the expense of patients.. Which is why no one writing about specialty drugs mentions that reduce total health care spending are only 5 percent of total health care spending.